Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities.
Cell Rep. 2022 Mar 1;38(9):110448. doi: 10.1016/j.celrep.2022.110448.
Cell Rep. 2022.
PMID: 35235778
Free PMC article.
Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation.
Mohammadpour H, Tsuji T, MacDonald CR, Sarow JL, Rosenheck H, Daneshmandi S, Choi JE, Qiu J, Matsuzaki J, Witkiewicz AK, Attwood K, Blazar BR, Odunsi K, Repasky EA, McCarthy PL.
Mohammadpour H, et al. Among authors: rosenheck h.
Cell Rep. 2023 Mar 28;42(3):112250. doi: 10.1016/j.celrep.2023.112250. Epub 2023 Mar 15.
Cell Rep. 2023.
PMID: 36924493
Free PMC article.
Item in Clipboard
Pharmacologically targeting KRAS G12D in PDAC models: tumor cell intrinsic and extrinsic impact.
Kumarasamy V, Frangou C, Wang J, Wan Y, Dynka A, Rosenheck H, Dey P, Abel EV, Knudsen ES, Witkiewicz AK.
Kumarasamy V, et al. Among authors: rosenheck h.
bioRxiv [Preprint]. 2023 Apr 20:2023.03.18.533261. doi: 10.1101/2023.03.18.533261.
bioRxiv. 2023.
PMID: 37162905
Free PMC article.
Preprint.
Item in Clipboard
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer.
Kumarasamy V, Wang J, Frangou C, Wan Y, Dynka A, Rosenheck H, Dey P, Abel EV, Knudsen ES, Witkiewicz AK.
Kumarasamy V, et al. Among authors: rosenheck h.
Cancer Res. 2024 Apr 1;84(7):1115-1132. doi: 10.1158/0008-5472.CAN-23-2504.
Cancer Res. 2024.
PMID: 38294344
Free PMC article.
Item in Clipboard
RB loss determines selective resistance and novel vulnerabilities in ER-positive breast cancer models.
Kumarasamy V, Nambiar R, Wang J, Rosenheck H, Witkiewicz AK, Knudsen ES.
Kumarasamy V, et al. Among authors: rosenheck h.
Oncogene. 2022 Jul;41(27):3524-3538. doi: 10.1038/s41388-022-02362-2. Epub 2022 Jun 9.
Oncogene. 2022.
PMID: 35676324
Free PMC article.
Item in Clipboard
Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer.
Fountzilas C, Bajor DL, Mukherjee S, Saltzman J, Witkiewicz AK, Maguire O, Minderman H, Nambiar R, Rosenheck HR, Knudsen ES, Muhitch JB, Abrams SI, Wang C, Hutson AD, Attwood K, Hicks KA, Jurcevic JA, Kalinski P, Iyer R, Boland PM.
Fountzilas C, et al. Among authors: rosenheck hr.
Clin Cancer Res. 2021 Dec 15;27(24):6726-6736. doi: 10.1158/1078-0432.CCR-21-1650. Epub 2021 Oct 13.
Clin Cancer Res. 2021.
PMID: 34645646
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite